Icahn School of Medicine | GenomeWeb

Icahn School of Medicine

A genome-wide association study meta-analysis that used average principal components to consider composite body shape traits led to six new genetic loci.

Researchers at the annual meeting of the American Association for Cancer Research discussed their efforts to use genomics to protect patients from radiotherapy toxicity.

By analyzing genomic data from nearly 590,000 apparently healthy individuals, researchers uncovered 13 carriers of serious Mendelian disease mutations.

Researchers are combining identity-by-descent-based ancestry information with electronic health records and self-reported ancestry information for thousands of New Yorkers. 

The designation includes an $8.5 million grant, which will be used to support research programs, facilitate researcher recruitment, and improve community engagement.

The Harris Center for Precision Wellness will leverage emerging technologies in genomics, digital health, and data science. 

In a paper published online in Nature Communications today, the researchers described their approach, called single-molecule modification analysis of long reads (SMALR), and tested it on seven bacterial strains.

The HealthSeq project followed 35 individuals after whole-genome sequencing while the survey tracked responses from 7,000 hypothetical study participants.

Thirteen institutions and life sciences companies have teamed up to launch the free repository that will offer access to allele frequency information from genomes and exomes.

Bioo licensed technology to reduce ligation bias in NGS and has incorporated it into its RNA-seq library prep kit.

Pages

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.